AstraZeneca makes $1.8 billion move for US blood pressure drug maker CinCor as pharmaceutical giant expands heart and kidney portfolio…
Read More »AstraZeneca
AstraZeneca has approved two cancer drugs for use in the EU just days after lung cancer trial setback Imfinzi gets…
Read More »AstraZeneca suffers setback as its highly profitable drug Imfinzi falls short in key lung cancer trial By Calum Muirhead for…
Read More »AstraZeneca is no longer trying to get its Covid vaccine in the US after regulators refused to sign the shot.…
Read More »AstraZeneca raises full-year expectations as cancer drug revenue offsets declining sales of Covid-19 vaccines AstraZeneca Has Raised Its Earnings Expectations…
Read More »